| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.45e-10 | 35 | 181 | 8 | GO:0015020 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.56e-08 | 11 | 181 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.08e-07 | 14 | 181 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 BRIP1 TWNK ERVK-7 MSH5 ERVK-10 HELQ DNASE2B RECQL4 ERVK-8 EXOG ERVK-11 ENDOG TOP2B | 1.25e-07 | 262 | 181 | 14 | GO:0140097 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 9.40e-07 | 37 | 181 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.05e-06 | 21 | 181 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.11e-06 | 38 | 181 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 7.49e-06 | 79 | 181 | 7 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.99e-05 | 37 | 181 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYOT ANK2 MYO5B MYO6 PPP1R9A CAPN1 BRSK2 GBP2 GRIA2 DAXX MAPK8IP3 ERMN AGBL4 PPARGC1A STARD9 AVIL MAST1 CDK5RAP2 RP1 BRSK1 MAPK8 SCIN UNC13A MYO16 DMTN | 2.06e-05 | 1099 | 181 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.28e-05 | 38 | 181 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity | 3.42e-05 | 136 | 181 | 8 | GO:0004519 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 5.87e-05 | 46 | 181 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 7.90e-05 | 153 | 181 | 8 | GO:0008194 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 1.13e-04 | 28 | 181 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 TES NSD1 ZMYM2 CPD ERVK-7 IDE ERVK-10 CLPX TRIP12 AGBL4 ZNF22 RNPEP TRIM56 RECQL4 ERVK-8 ZNF638 UHRF1 ERVK-11 ZMYM3 | 1.76e-04 | 891 | 181 | 20 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.45e-04 | 136 | 181 | 7 | GO:0004540 | |
| GeneOntologyMolecularFunction | spectrin binding | 2.45e-04 | 34 | 181 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 BRIP1 DHX40 TWNK ERVK-7 DHX33 MSH5 ERVK-10 HELQ DNASE2B RECQL4 ERVK-8 EXOG ERVK-11 ENDOG TOP2B | 2.70e-04 | 645 | 181 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 4.35e-04 | 70 | 181 | 5 | GO:0008235 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | BRIP1 MYO5B MYO6 DHX40 TWNK DHX33 MSH5 IDE CLPX HELQ ATP10D MDN1 STARD9 RECQL4 TOP2B | 4.92e-04 | 614 | 181 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 6.98e-04 | 211 | 181 | 8 | GO:0016758 | |
| GeneOntologyMolecularFunction | retinoid binding | 9.31e-04 | 48 | 181 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 CAPN1 USP24 CPD ERVK-7 IDE ERVK-10 CLPX AGBL4 RNPEP ERVK-8 ERVK-18 ADAM17 ERVK-25 METAP2 | 9.37e-04 | 654 | 181 | 15 | GO:0008233 |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.01e-03 | 49 | 181 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.07e-03 | 127 | 181 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.12e-03 | 227 | 181 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.14e-03 | 23 | 181 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | nuclease activity | 1.25e-03 | 231 | 181 | 8 | GO:0004518 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT2A2 EXT1 ST6GAL2 UGT2A3 UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 | 1.29e-03 | 288 | 181 | 9 | GO:0016757 |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.35e-03 | 53 | 181 | 4 | GO:0030331 | |
| GeneOntologyMolecularFunction | histone deacetylase regulator activity | 1.67e-03 | 7 | 181 | 2 | GO:0035033 | |
| GeneOntologyMolecularFunction | tumor necrosis factor binding | 1.67e-03 | 7 | 181 | 2 | GO:0043120 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | BRIP1 MYO5B DHX40 TWNK DHX33 IDE CLPX HELQ ATP10D MDN1 RECQL4 | 2.36e-03 | 441 | 181 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.42e-03 | 62 | 181 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 TES NSD1 ZMYM2 CPD ERVK-7 IDE ERVK-10 CLPX TRIP12 AGBL4 ZNF22 RNPEP TCHHL1 TRIM56 RECQL4 ERVK-8 ZNF638 UHRF1 ERVK-11 ZMYM3 | 2.63e-03 | 1189 | 181 | 21 | GO:0046914 |
| GeneOntologyMolecularFunction | helicase activity | 3.22e-03 | 158 | 181 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 3.29e-03 | 110 | 181 | 5 | GO:0008238 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 4.20e-10 | 21 | 184 | 7 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.29e-09 | 26 | 184 | 7 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.29e-09 | 26 | 184 | 7 | GO:0006063 | |
| GeneOntologyBiologicalProcess | DNA integration | 6.50e-08 | 13 | 184 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 4.17e-07 | 8 | 184 | 4 | GO:0070980 | |
| GeneOntologyBiologicalProcess | DNA recombination | ANKRD31 ERVK-6 BRIP1 NFKBIZ ERVK-7 MSH5 ERVK-10 HELQ SLF2 RECQL4 ERVK-8 UHRF1 ERVK-11 ENDOG TOP2B | 1.16e-06 | 368 | 184 | 15 | GO:0006310 |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.23e-06 | 10 | 184 | 4 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.87e-06 | 12 | 184 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | ERVK-6 TWNK ERVK-7 ERVK-10 PRIM2 RECQL4 ERVK-8 BOD1L1 ERVK-11 ENDOG | 4.66e-06 | 178 | 184 | 10 | GO:0006261 |
| GeneOntologyBiologicalProcess | neuron development | AHI1 MYOT RASGRF1 MYO5B MYO6 PPP1R9A MINK1 BRSK2 EXT1 NPHP4 ZNF804A TIAM2 MAPK8IP3 AGBL4 CDKL5 PBRM1 PTPRD AVIL DOCK7 KCNQ3 ADAM17 RP1 CDC20 BRSK1 MAPK8 TNXB UNC13A MYO16 TOP2B ANKS1A | 1.57e-05 | 1463 | 184 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | DNA metabolic process | ANKRD31 ERVK-6 BRIP1 TWNK NFKBIZ ERVK-7 MSH5 ERVK-10 HELQ TRIP12 DNASE2B PBRM1 SLF2 PRIM2 RECQL4 ERVK-8 UHRF1 BOD1L1 EXOG SMPD3 MAPK8 ERVK-11 ENDOG TOP2B | 3.54e-05 | 1081 | 184 | 24 | GO:0006259 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 6.71e-05 | 48 | 184 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 9.90e-05 | 52 | 184 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | DNA replication | ERVK-6 TWNK ERVK-7 ERVK-10 PRIM2 RECQL4 ERVK-8 BOD1L1 MAPK8 ERVK-11 ENDOG | 1.18e-04 | 312 | 184 | 11 | GO:0006260 |
| GeneOntologyBiologicalProcess | neuron projection development | AHI1 MYOT RASGRF1 MYO5B MYO6 PPP1R9A MINK1 BRSK2 EXT1 ZNF804A TIAM2 MAPK8IP3 CDKL5 PBRM1 PTPRD AVIL DOCK7 ADAM17 CDC20 BRSK1 MAPK8 TNXB UNC13A MYO16 TOP2B | 1.97e-04 | 1285 | 184 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in establishment of planar polarity | 2.36e-04 | 3 | 184 | 2 | GO:0090176 | |
| GeneOntologyCellularComponent | axon | MYOT RASGRF1 MYO6 PPP1R9A MINK1 BRSK2 GRIA2 ZNF804A SYT7 TIAM2 MAPK8IP3 ERMN AGBL4 CDKL5 AVIL DOCK7 MAST1 KCNAB1 KCNQ3 BRSK1 MAPK8 CNGA1 UNC13A | 4.63e-06 | 891 | 186 | 23 | GO:0030424 |
| GeneOntologyCellularComponent | distal axon | RASGRF1 PPP1R9A BRSK2 GRIA2 ZNF804A SYT7 TIAM2 MAPK8IP3 CDKL5 DOCK7 BRSK1 CNGA1 UNC13A | 1.48e-04 | 435 | 186 | 13 | GO:0150034 |
| GeneOntologyCellularComponent | dendrite cytoplasm | 3.91e-04 | 39 | 186 | 4 | GO:0032839 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 4.32e-04 | 40 | 186 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 4.56e-04 | 110 | 186 | 6 | GO:0120111 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 6.05e-04 | 19 | 186 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | TLK2 ANK2 MYO5B MYO6 BRSK2 PPP1R13B GBP2 CPD CEP43 MAPK8IP3 TG CDKL5 NCOR1 ZNF35 CDK5RAP2 CDC20 ENDOG MYO16 DMTN | 6.91e-04 | 934 | 186 | 19 | GO:0048471 |
| Domain | UDPGT | 2.90e-08 | 21 | 174 | 6 | PF00201 | |
| Domain | UDPGT | 2.90e-08 | 21 | 174 | 6 | PS00375 | |
| Domain | UDP_glucos_trans | 2.90e-08 | 21 | 174 | 6 | IPR002213 | |
| Domain | Ank_2 | ANKRD31 GLS2 ANK2 PPP1R13B NFKBIZ ASB13 OSTF1 ANKRD52 MYO16 INVS ANKS1A | 5.68e-06 | 215 | 174 | 11 | PF12796 |
| Domain | Ank | ANKRD31 GLS2 ANK2 PPP1R13B NFKBIZ ASB13 OSTF1 ANKRD52 MYO16 INVS ANKS1A | 9.91e-06 | 228 | 174 | 11 | PF00023 |
| Domain | - | ANKRD31 GLS2 ANK2 PPP1R13B NFKBIZ ASB13 OSTF1 ANKRD52 MYO16 INVS ANKS1A | 2.17e-05 | 248 | 174 | 11 | 1.25.40.20 |
| Domain | ANK | ANKRD31 GLS2 ANK2 PPP1R13B NFKBIZ ASB13 OSTF1 ANKRD52 MYO16 INVS ANKS1A | 2.43e-05 | 251 | 174 | 11 | SM00248 |
| Domain | ANK_REPEAT | ANKRD31 GLS2 ANK2 PPP1R13B NFKBIZ ASB13 OSTF1 ANKRD52 MYO16 INVS ANKS1A | 2.61e-05 | 253 | 174 | 11 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD31 GLS2 ANK2 PPP1R13B NFKBIZ ASB13 OSTF1 ANKRD52 MYO16 INVS ANKS1A | 2.71e-05 | 254 | 174 | 11 | IPR020683 |
| Domain | ANK_REP_REGION | ANKRD31 GLS2 ANK2 PPP1R13B NFKBIZ ASB13 OSTF1 ANKRD52 MYO16 INVS ANKS1A | 2.71e-05 | 254 | 174 | 11 | PS50297 |
| Domain | Ankyrin_rpt | ANKRD31 GLS2 ANK2 PPP1R13B NFKBIZ ASB13 OSTF1 ANKRD52 MYO16 INVS ANKS1A | 3.60e-05 | 262 | 174 | 11 | IPR002110 |
| Domain | NUCLEASE_NON_SPEC | 8.63e-05 | 2 | 174 | 2 | PS01070 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.04e-04 | 35 | 174 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 4.19e-04 | 38 | 174 | 4 | PS00690 | |
| Pathway | WP_GLUCURONIDATION | 5.41e-11 | 25 | 135 | 8 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 7.76e-11 | 26 | 135 | 8 | M39404 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.91e-09 | 24 | 135 | 7 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.63e-09 | 25 | 135 | 7 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.05e-07 | 25 | 135 | 6 | M605 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.80e-07 | 44 | 135 | 7 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.12e-07 | 45 | 135 | 7 | MM15694 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.19e-07 | 28 | 135 | 6 | M19580 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 5.90e-07 | 52 | 135 | 7 | M14171 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.36e-06 | 41 | 135 | 6 | M7399 | |
| Pathway | WP_JOUBERT_SYNDROME | 7.97e-06 | 76 | 135 | 7 | M39835 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 8.72e-06 | 51 | 135 | 6 | M17726 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.36e-05 | 55 | 135 | 6 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 3.28e-05 | 64 | 135 | 6 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 5.47e-05 | 70 | 135 | 6 | M16794 | |
| Pathway | REACTOME_PREDNISONE_ADME | 6.18e-05 | 23 | 135 | 4 | MM16639 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 6.42e-05 | 72 | 135 | 6 | M9257 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 7.44e-05 | 107 | 135 | 7 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 8.36e-05 | 109 | 135 | 7 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 8.36e-05 | 109 | 135 | 7 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 1.45e-04 | 119 | 135 | 7 | MM15692 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 3.77e-04 | 183 | 135 | 8 | M39588 | |
| Pathway | WP_CILIOPATHIES | 3.91e-04 | 184 | 135 | 8 | M39880 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.10e-04 | 39 | 135 | 4 | MM15695 | |
| Pathway | WP_FARNESOID_X_RECEPTOR_PATHWAY | 7.44e-04 | 19 | 135 | 3 | M39411 | |
| Pubmed | 2.55e-10 | 8 | 190 | 5 | 18719240 | ||
| Pubmed | RALGAPA1 MYO5B PPP1R9A MINK1 PPP1R13B SLC6A15 CPD IDE CLPX CEMIP2 TULP3 NCOR1 PTPRD STXBP3 CSK SLC4A1AP PRIM2 ZNF638 NHS CDK5RAP2 MAPK8 PIBF1 SCIN ANKRD52 FKBP5 | 7.42e-10 | 1049 | 190 | 25 | 27880917 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | BRIP1 ZNF280D NSD1 ZMYM2 DAXX TRIP12 CASZ1 FSIP2 PBRM1 UBN1 SLC4A1AP RBMX2 ZBTB21 UHRF1 BOD1L1 METAP2 ZMYM3 TOP2B AFF4 | 1.23e-09 | 608 | 190 | 19 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TLK2 BRIP1 MINK1 USP24 ZMYM2 DAXX TRIP12 MAPK8IP3 NCOR1 MDN1 UBN1 SLC4A1AP RBMX2 ZBTB21 ZNF638 MAPK8 SF3B2 FKBP5 ZMYM3 TOP2B ANKS1A | 1.98e-09 | 774 | 190 | 21 | 15302935 |
| Pubmed | TLK2 ANK2 PPP1R9A MINK1 NSD1 ZMYM2 GRIA2 MAPK8IP3 NCOR1 PBRM1 MDN1 PTPRD NFATC3 KIAA1217 ZBTB21 DOCK7 KCNAB1 CDK5RAP2 EXOG BRSK1 UNC13A AFF4 ANKS1A | 3.60e-09 | 963 | 190 | 23 | 28671696 | |
| Pubmed | TLK2 BRIP1 DHX40 ZMYM2 PPHLN1 DAXX MDN1 UBN1 SLF2 ZBTB21 SPTY2D1 AFF4 | 4.06e-09 | 222 | 190 | 12 | 37071664 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RALGAPA1 MPZ ANK2 WWP1 PPP1R9A MINK1 SLC6A15 CPD PLEKHN1 SYT7 ATP10D CEMIP2 TULP3 JPH1 CDKL5 STXBP3 DOCK7 | 1.84e-08 | 569 | 190 | 17 | 30639242 |
| Pubmed | 2.98e-08 | 7 | 190 | 4 | 26074487 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 BDP1 NRIP1 MYO6 WWP1 PPP1R9A CAPN1 MINK1 PPHLN1 CPD MSH5 IDE CEP43 CASZ1 TULP3 MAPK8IP3 EVA1C KIAA1217 ZNF638 MAST1 BOD1L1 OSTF1 FKBP5 RIC1 AFF4 INVS ANKS1A | 4.76e-08 | 1489 | 190 | 27 | 28611215 |
| Pubmed | 5.94e-08 | 8 | 190 | 4 | 32093886 | ||
| Pubmed | 5.94e-08 | 8 | 190 | 4 | 10748067 | ||
| Pubmed | 5.94e-08 | 8 | 190 | 4 | 20142249 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 MINK1 BRSK2 TRIP12 TMCC3 FSIP2 MDN1 NFATC3 SLF2 STARD9 KIAA1217 ZBTB21 DOCK7 NHS GAN BOD1L1 CDC20 PIBF1 DMTN ANKS1A | 6.34e-08 | 861 | 190 | 20 | 36931259 |
| Pubmed | 1.60e-07 | 3 | 190 | 3 | 29138287 | ||
| Pubmed | 1.60e-07 | 3 | 190 | 3 | 7835904 | ||
| Pubmed | 1.60e-07 | 3 | 190 | 3 | 23223495 | ||
| Pubmed | 1.60e-07 | 3 | 190 | 3 | 19858781 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 NRIP1 DHX40 ZMYM2 PPP1R13B DAXX NCOR1 UBN1 NFATC3 SLF2 KIAA1217 CDC20 SCIN ANKRD52 FKBP5 ZMYM3 | 1.75e-07 | 588 | 190 | 16 | 38580884 |
| Pubmed | RALGAPA1 ANK2 KCTD13 MYO5B MYO6 PPP1R9A MINK1 BRSK2 GRIA2 PGM1 MAPK8IP3 ERMN AGBL4 CDKL5 NWD2 RNPEP KIAA1217 DOCK7 MAST1 KCNQ3 BRSK1 METAP2 UNC13A DMTN SEC13 | 3.15e-07 | 1431 | 190 | 25 | 37142655 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 4.13e-07 | 12 | 190 | 4 | 20308471 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.39e-07 | 4 | 190 | 3 | 10469592 | |
| Pubmed | 6.39e-07 | 4 | 190 | 3 | 26176234 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 8.91e-07 | 94 | 190 | 7 | 21542922 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.59e-06 | 5 | 190 | 3 | 12629516 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 15318931 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TLK2 TES ZMYM2 IDE CLPX EDIL3 CEP43 JPH1 PBRM1 CSK RBMX2 RECQL4 CDK5RAP2 CDC20 PIBF1 DCAF4 SF3B2 ZMYM3 TOP2B SEC13 DCAF12 | 1.60e-06 | 1155 | 190 | 21 | 20360068 |
| Pubmed | 1.65e-06 | 103 | 190 | 7 | 10574462 | ||
| Pubmed | 2.49e-06 | 18 | 190 | 4 | 18664271 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | RALGAPA1 TES MYO5B MYO6 CAPN1 SLC6A15 IDE CEP43 FOXRED2 HEATR6 MDN1 STXBP3 PRIM2 CDK5RAP2 PIBF1 SPTY2D1 | 4.45e-06 | 754 | 190 | 16 | 33060197 |
| Pubmed | 6.19e-06 | 234 | 190 | 9 | 36243803 | ||
| Pubmed | MYO6 MINK1 SLC6A15 TRIP12 CEMIP2 CDKL5 NCOR1 DNASE2B SLC30A5 DOCK7 ZNF638 CDK5RAP2 HCFC2 SPTY2D1 CDON SEC13 | 6.48e-06 | 777 | 190 | 16 | 35844135 | |
| Pubmed | 8.81e-06 | 8 | 190 | 3 | 22579593 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | TLK2 RALGAPA1 DHX40 ZMYM2 PPHLN1 DAXX DHX33 TRIP12 MDN1 SLC4A1AP ZNF638 UHRF1 BOD1L1 CDC20 SPTY2D1 SF3B2 TOP2B AFF4 | 9.15e-06 | 989 | 190 | 18 | 36424410 |
| Pubmed | RALGAPA1 BRIP1 TES SLC6A15 PPHLN1 CEMIP2 JPH1 STXBP3 ZNF638 BOD1L1 CDC20 TIMM44 SF3B2 FKBP5 ANKS1A | 1.37e-05 | 733 | 190 | 15 | 34672954 | |
| Pubmed | 1.87e-05 | 10 | 190 | 3 | 20592197 | ||
| Pubmed | PPP1R9A MINK1 PPP1R13B SLC6A15 CPD CEMIP2 JPH1 SLC30A5 STXBP3 KIAA1217 NHS | 2.25e-05 | 421 | 190 | 11 | 36976175 | |
| Pubmed | RALGAPA1 ANK2 MYO6 MINK1 TWNK SLC6A15 CPD CLPX TMCC3 CEMIP2 JPH1 MDN1 STXBP3 SLC4A1AP CDK5RAP2 PIBF1 TIMM44 ENDOG ANKRD52 SF3B2 FKBP5 TOP2B | 2.32e-05 | 1487 | 190 | 22 | 33957083 | |
| Pubmed | SPATA7 maintains a novel photoreceptor-specific zone in the distal connecting cilium. | 2.56e-05 | 11 | 190 | 3 | 29899041 | |
| Pubmed | DHX40 SLC39A11 PPP1R9A MINK1 NSD1 ZMYM2 TWNK PPHLN1 DAXX DHX33 SYT7 CASZ1 PBRM1 MDN1 SLC4A1AP RBMX2 TRIM56 HCFC2 SPTY2D1 ZMYM3 AFF4 SEC13 | 2.56e-05 | 1497 | 190 | 22 | 31527615 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 27175020 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 10222050 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 32660355 | ||
| Pubmed | The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5. | 2.97e-05 | 2 | 190 | 2 | 29618004 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 28962835 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 1909870 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 24121496 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 17263731 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 24267955 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 22170718 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 18804538 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 15319348 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 2.97e-05 | 2 | 190 | 2 | 3105095 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 17848572 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 27496708 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 27018747 | ||
| Pubmed | Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex. | 2.97e-05 | 2 | 190 | 2 | 30307479 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 17698910 | ||
| Pubmed | A possible 5'-NRIP1/UHRF1-3' fusion gene detected by array CGH analysis in a Ph+ ALL patient. | 2.97e-05 | 2 | 190 | 2 | 22285022 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 26055704 | ||
| Pubmed | Cloning and characterization of myr 6, an unconventional myosin of the dilute/myosin-V family. | 2.97e-05 | 2 | 190 | 2 | 8855265 | |
| Pubmed | NRIP1/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome. | 2.97e-05 | 2 | 190 | 2 | 24698981 | |
| Pubmed | Oxidative status of muscle is determined by p107 regulation of PGC-1alpha. | 2.97e-05 | 2 | 190 | 2 | 20713602 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 17687269 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 23986585 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 2.97e-05 | 2 | 190 | 2 | 3117546 | |
| Pubmed | HPV16 E7 protein antagonizes TNF-α-induced apoptosis of cervical cancer cells via Daxx/JNK pathway. | 2.97e-05 | 2 | 190 | 2 | 37871853 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 16630837 | ||
| Pubmed | Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. | 2.97e-05 | 2 | 190 | 2 | 21979051 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 19282672 | ||
| Pubmed | The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. | 2.97e-05 | 2 | 190 | 2 | 35039640 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 11376859 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 28228532 | ||
| Pubmed | Opposing action of NCoR1 and PGC-1α in mitochondrial redox homeostasis. | 2.97e-05 | 2 | 190 | 2 | 31408725 | |
| Pubmed | Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. | 2.97e-05 | 2 | 190 | 2 | 10359671 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.97e-05 | 2 | 190 | 2 | 11672541 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 15666817 | ||
| Pubmed | Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation. | 2.97e-05 | 2 | 190 | 2 | 18339622 | |
| Pubmed | 3.40e-05 | 12 | 190 | 3 | 18161889 | ||
| Pubmed | 4.41e-05 | 13 | 190 | 3 | 21880919 | ||
| Pubmed | 4.41e-05 | 13 | 190 | 3 | 22863007 | ||
| Pubmed | 5.13e-05 | 73 | 190 | 5 | 22094256 | ||
| Pubmed | NRIP1 MYO6 DHX40 USP24 ZMYM2 IDE CASZ1 NCOR1 PBRM1 MDN1 CDK5RAP2 C5 ANKRD52 | 5.43e-05 | 638 | 190 | 13 | 31182584 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 6.72e-05 | 125 | 190 | 6 | 32891193 | |
| Pubmed | ANK2 MYO6 PPHLN1 CLPX TRIP12 PBRM1 TCHHL1 STARD9 RBMX2 TRIM56 DOCK7 UHRF1 C5 CDC20 TIMM44 METAP2 SPTY2D1 SF3B2 AFF4 SEC13 | 6.75e-05 | 1371 | 190 | 20 | 36244648 | |
| Pubmed | CAPN1 USP24 NSD1 TRIP12 PBRM1 MDN1 RNPEP DOCK7 ZNF638 ANKRD52 SF3B2 ZMYM3 SEC13 | 6.86e-05 | 653 | 190 | 13 | 22586326 | |
| Pubmed | 7.73e-05 | 251 | 190 | 8 | 31076518 | ||
| Pubmed | NRIP1 ANK2 MYO6 ZNF423 GNPTAB ZMYM2 EDIL3 TRIP12 MAPK8IP3 JPH1 HEATR6 PTPRD SLF2 HECTD2 MAST1 SMPD3 METAP2 SF3B2 AFF4 | 8.68e-05 | 1285 | 190 | 19 | 35914814 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 12376738 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 19572376 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 22669945 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 26385605 | ||
| Pubmed | Aging of spermatogonial stem cells by Jnk-mediated glycolysis activation. | 8.87e-05 | 3 | 190 | 2 | 31358627 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 16141199 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 9971820 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 28617439 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 19036714 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 19574423 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 31283791 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 32176075 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 18794372 | ||
| Interaction | TRIM52 interactions | BRIP1 DHX40 KIAA0586 NPHP4 CEP43 NCOR1 RECQL4 CDK5RAP2 TOP2B INVS | 3.12e-07 | 133 | 179 | 10 | int:TRIM52 |
| Interaction | NUP43 interactions | BRIP1 ZNF280D NSD1 ZMYM2 PPHLN1 CCDC168 TRIP12 FSIP2 NCOR1 PBRM1 SLF2 RBMX2 RECQL4 BOD1L1 HCFC2 ZMYM3 TOP2B SEC13 | 1.22e-05 | 625 | 179 | 18 | int:NUP43 |
| Interaction | PIBF1 interactions | AHI1 USP24 DAXX C7orf57 CEP43 AGBL4 ZNF35 CSK CDK5RAP2 PIBF1 | 1.25e-05 | 200 | 179 | 10 | int:PIBF1 |
| Interaction | UGT2B15 interactions | 1.35e-05 | 6 | 179 | 3 | int:UGT2B15 | |
| Interaction | UGT2A3 interactions | 1.35e-05 | 6 | 179 | 3 | int:UGT2A3 | |
| Interaction | YWHAH interactions | RALGAPA1 NRIP1 KCTD13 MINK1 TWNK PPHLN1 TRIP12 TMCC3 RNPEP CSK NFATC3 SLF2 STARD9 KIAA1217 RECQL4 ZBTB21 DOCK7 ZNF638 MAST1 NHS BOD1L1 CDC20 PIBF1 DMTN ANKS1A | 1.52e-05 | 1102 | 179 | 25 | int:YWHAH |
| Interaction | BRSK1 interactions | 3.41e-05 | 42 | 179 | 5 | int:BRSK1 | |
| Interaction | H3C3 interactions | BRIP1 ZNF280D NSD1 ZMYM2 DAXX TRIP12 FSIP2 PBRM1 RBMX2 UHRF1 BOD1L1 METAP2 ZMYM3 TOP2B AFF4 | 3.76e-05 | 495 | 179 | 15 | int:H3C3 |
| Interaction | TNIK interactions | TLK2 ANK2 MINK1 ZMYM2 PPP1R13B GRIA2 CEP43 TIAM2 CDKL5 PTPRD KIAA1217 DOCK7 UNC13A | 3.79e-05 | 381 | 179 | 13 | int:TNIK |
| Interaction | USP7 interactions | ANKRD31 MYOT KCTD13 DHX40 ZNF423 MINK1 USP24 NSD1 DAXX TRIP12 TULP3 CDKL5 PBRM1 MDN1 UBN1 CSK RECQL4 DOCK7 ZNF638 UHRF1 DCAF4 SF3B2 FKBP5 TOP2B AFF4 DMTN ANKS1A | 3.81e-05 | 1313 | 179 | 27 | int:USP7 |
| Interaction | H3C1 interactions | TLK2 BRIP1 ANK2 ZNF280D MYO6 CAPN1 NSD1 ZMYM2 DAXX CLPX TRIP12 NCOR1 PBRM1 UBN1 ZNF638 UHRF1 CDC20 TIMM44 SF3B2 TOP2B AFF4 | 5.28e-05 | 901 | 179 | 21 | int:H3C1 |
| Interaction | RAD18 interactions | ZMYM2 CPD TULP3 SLC4A1AP SLF2 RBMX2 RECQL4 ZNF638 UHRF1 MAPK8 TIMM44 SPTY2D1 ZMYM3 TOP2B | 6.12e-05 | 457 | 179 | 14 | int:RAD18 |
| Interaction | LYN interactions | ANK2 MYO6 ZNF423 PPP1R9A MINK1 PPP1R13B SLC6A15 DHX33 CEP43 CEMIP2 TULP3 JPH1 STXBP3 CSK KIAA1217 DOCK7 PRRG4 TOP2B | 7.76e-05 | 720 | 179 | 18 | int:LYN |
| Interaction | UGT2A2 interactions | 7.85e-05 | 2 | 179 | 2 | int:UGT2A2 | |
| Interaction | ERMN interactions | 7.90e-05 | 10 | 179 | 3 | int:ERMN | |
| Cytoband | 4q13 | 3.34e-09 | 15 | 190 | 5 | 4q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 4.49e-06 | 157 | 190 | 7 | chr4q13 | |
| Cytoband | 7q34 | 7.36e-05 | 167 | 190 | 6 | 7q34 | |
| GeneFamily | UDP glucuronosyltransferases | 9.72e-10 | 32 | 114 | 7 | 363 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD31 GLS2 ANK2 PPP1R13B NFKBIZ ASB13 OSTF1 ANKRD52 MYO16 INVS ANKS1A | 3.77e-07 | 242 | 114 | 11 | 403 |
| GeneFamily | T cell receptor beta locus at 7q34 | 2.23e-04 | 87 | 114 | 5 | 372 | |
| GeneFamily | Zinc fingers MYM-type | 5.81e-04 | 6 | 114 | 2 | 86 | |
| GeneFamily | Gelsolin/villins | 1.08e-03 | 8 | 114 | 2 | 950 | |
| GeneFamily | DEAH-box helicases | 4.46e-03 | 16 | 114 | 2 | 500 | |
| GeneFamily | Aminopeptidases|CD molecules | 5.04e-03 | 17 | 114 | 2 | 104 | |
| GeneFamily | DNA helicases | 5.04e-03 | 17 | 114 | 2 | 1167 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 5.64e-03 | 18 | 114 | 2 | 498 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.80e-03 | 181 | 114 | 5 | 694 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 TES TMEM74B ANK2 PPP1R9A GNPTAB BRSK2 GRIA2 SLC6A15 DHX33 CASZ1 JPH1 FSIP2 PPARGC1A ST6GAL2 MDN1 MAST1 KCNQ3 BOD1L1 SMPD3 HCFC2 SCIN UNC13A DMTN CDON | 1.90e-07 | 1106 | 181 | 25 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | BDP1 PPP1R9A EXT1 AGBL4 PTPRD SLC13A1 KIAA1217 UGT2B7 NHS FKBP5 | 4.33e-07 | 176 | 181 | 10 | M39223 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 NRIP1 AHI1 MYO6 WWP1 GNPTAB EXT1 PPARGC1A ZNF22 PBRM1 SLC30A5 STXBP3 SLC4A1AP ZNF638 CDK5RAP2 PIBF1 METAP2 TOP2B | 7.53e-07 | 656 | 181 | 18 | M18979 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | RALGAPA1 AHI1 NFKBIZ EXT1 AGBL4 PPARGC1A KIAA1217 MAPK8 SCIN AFF4 | 7.07e-06 | 240 | 181 | 10 | M39236 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | BDP1 TMEM74B ANK2 GNPTAB GRIA2 EDIL3 SYT7 CASZ1 CDKL5 PPARGC1A ST6GAL2 MAST1 SMPD3 BRSK1 UNC13A FAM131B DMTN | 8.29e-06 | 703 | 181 | 17 | M39070 |
| Coexpression | GSE14308_TH2_VS_NATURAL_TREG_DN | 1.07e-05 | 199 | 181 | 9 | M3369 | |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 1.77e-05 | 162 | 181 | 8 | M6847 | |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN | 2.68e-05 | 125 | 181 | 7 | M8930 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP | 5.29e-05 | 139 | 181 | 7 | M6754 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | TMEM74B ANK2 SLC6A15 EDIL3 SYT7 CASZ1 TMCC3 MAST1 KCNAB1 KCNQ3 SMPD3 UNC13A DMTN | 5.40e-05 | 506 | 181 | 13 | M39067 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | RALGAPA1 OLAH KCTD13 ZNF280D MYO5B RGS22 PPP1R9A IDE CUBN SYT7 CASZ1 GJB5 SLC13A1 PRIM2 UGT2A1 UGT2B7 KCNQ3 BOD1L1 CNGA1 TNXB UNC13A MTRF1L | 7.85e-05 | 1281 | 181 | 22 | M1884 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN | 7.91e-05 | 200 | 181 | 8 | M8110 | |
| Coexpression | GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN | 7.91e-05 | 200 | 181 | 8 | M5834 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN | 7.91e-05 | 200 | 181 | 8 | M9839 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 9.29e-05 | 152 | 181 | 7 | M39239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TLK2 NRIP1 WWP1 USP24 ZMYM2 EXT1 TRIP12 ZNF804A MDN1 STXBP3 NFATC3 PRIM2 ZNF638 ADAM17 MAPK8 PIBF1 ANKS1A | 9.77e-05 | 856 | 181 | 17 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML1 | 1.01e-04 | 328 | 181 | 10 | M39064 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TLK2 NRIP1 USP24 ZMYM2 EXT1 TRIP12 ZNF804A MDN1 PRIM2 ZNF638 PIBF1 ANKS1A | 1.03e-04 | 466 | 181 | 12 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.04e-04 | 208 | 181 | 8 | M39233 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | 1.20e-04 | 335 | 181 | 10 | M39065 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.29e-06 | 157 | 178 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | RALGAPA1 BDP1 NRIP1 AHI1 PPP1R9A CPD IDE TRIP12 PPARGC1A KIAA1217 MAPK8 SPTY2D1 TOP2B | 1.77e-05 | 375 | 178 | 13 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | RALGAPA1 NSD1 CPD IDE ELOVL7 PPARGC1A NCOR1 HEATR6 KIAA1217 MAPK8 PIBF1 SCIN SF3B2 | 1.98e-05 | 379 | 178 | 13 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TLK2 AHI1 ANK2 ZNF280D RBL1 DHX40 ZNF423 KIAA0586 BRSK2 ZMYM2 PPHLN1 EXT1 CEMIP2 C19orf81 CDKL5 PPARGC1A ST6GAL2 ZNF22 HECTD2 RECQL4 DOCK7 BOD1L1 MAPK8 | 2.81e-05 | 1060 | 178 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.83e-05 | 186 | 178 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TLK2 BDP1 AHI1 ANK2 ZNF280D RBL1 DHX40 KIAA0586 NSD1 ZMYM2 PPHLN1 C19orf81 ASB13 ST6GAL2 ZNF22 MDN1 SLC4A1AP HECTD2 RBMX2 PRIM2 RECQL4 DOCK7 BOD1L1 MAPK8 PIBF1 | 5.15e-05 | 1257 | 178 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 5.18e-05 | 201 | 178 | 9 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | TLK2 BDP1 AHI1 ZNF280D KIAA0586 ZMYM2 NCOR1 HECTD2 BOD1L1 PIBF1 TOP2B | 6.63e-05 | 311 | 178 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | TLK2 RALGAPA1 BDP1 AHI1 GNPTAB KIAA0586 ZMYM2 CPD JPH1 PPARGC1A NCOR1 HEATR6 ZSCAN22 SLC4A1AP BOD1L1 PIBF1 TOP2B MTRF1L AFF4 | 7.41e-05 | 831 | 178 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | RALGAPA1 BDP1 ZNF280D RBL1 GNPTAB KIAA0586 ZMYM2 CPD CLPX HELQ HEATR6 ZSCAN22 SLC4A1AP HECTD2 DOCK7 TOP2B MTRF1L AFF4 | 1.03e-04 | 780 | 178 | 18 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | RALGAPA1 AHI1 RASGRF1 NSD1 CPD IDE ELOVL7 PPARGC1A NCOR1 HEATR6 KIAA1217 MAPK8 PIBF1 SCIN ENDOG SPTY2D1 SF3B2 TOP2B | 1.30e-04 | 795 | 178 | 18 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | RALGAPA1 AHI1 RASGRF1 CPD IDE ELOVL7 PPARGC1A NCOR1 HEATR6 MAPK8 SCIN SPTY2D1 | 1.55e-04 | 402 | 178 | 12 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_200 | 1.72e-04 | 62 | 178 | 5 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | RALGAPA1 NSD1 GRIA2 CPD IDE TRIP12 PPARGC1A HEATR6 METAP2 SF3B2 TOP2B | 2.95e-04 | 369 | 178 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.13e-04 | 202 | 178 | 8 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | NRIP1 BRIP1 TES ANK2 MYO5B RBL1 NFKBIZ EDIL3 TMCC3 ELOVL7 PPARGC1A ASB13 PTPRD RNPEP OSTF1 SPTY2D1 TOP2B | 3.14e-04 | 780 | 178 | 17 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO5B PPP1R9A NFKBIZ AGBL4 PTPRD SLC13A1 UGT2A3 UGT2B7 KCNQ3 NHS | 5.29e-09 | 186 | 182 | 10 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO5B PPP1R9A CUBN AGBL4 PTPRD SLC13A1 UGT2A3 UGT2B7 KCNQ3 NHS | 6.16e-09 | 189 | 182 | 10 | 28b502611829e4a24caff2562545c7db97686099 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-07 | 194 | 182 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-07 | 195 | 182 | 9 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.95e-07 | 158 | 182 | 8 | 1f94622186d8329357fa06785e03eeacf29ab1ce | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-07 | 162 | 182 | 8 | afffecc6c504930554aafc12c5bffa53e3c5b016 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.99e-07 | 183 | 182 | 8 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 186 | 182 | 8 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 187 | 182 | 8 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-06 | 187 | 182 | 8 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.10e-06 | 188 | 182 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-06 | 189 | 182 | 8 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-06 | 189 | 182 | 8 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.15e-06 | 189 | 182 | 8 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-06 | 191 | 182 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 193 | 182 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 193 | 182 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 194 | 182 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 196 | 182 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-06 | 198 | 182 | 8 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.75e-06 | 200 | 182 | 8 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.75e-06 | 200 | 182 | 8 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.75e-06 | 200 | 182 | 8 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-06 | 149 | 182 | 7 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 173 | 182 | 7 | 295bfe1efa648173c2d5981025bc61c576baf53f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.58e-06 | 174 | 182 | 7 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 8.17e-06 | 176 | 182 | 7 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.46e-06 | 180 | 182 | 7 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.46e-06 | 180 | 182 | 7 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.81e-06 | 181 | 182 | 7 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-06 | 181 | 182 | 7 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 9.81e-06 | 181 | 182 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 182 | 182 | 7 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-05 | 182 | 182 | 7 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 183 | 182 | 7 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.17e-05 | 186 | 182 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 186 | 182 | 7 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-05 | 187 | 182 | 7 | fa8f221b4c2df61eadaa9c77e4cf45848b00330b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 187 | 182 | 7 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 187 | 182 | 7 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.21e-05 | 187 | 182 | 7 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 188 | 182 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 189 | 182 | 7 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 189 | 182 | 7 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 189 | 182 | 7 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 189 | 182 | 7 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 126 | 182 | 6 | 65c7c0e4cfb5ac58d80b4034d42e9f662116e0d3 | |
| ToppCell | Bronchial-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 126 | 182 | 6 | b6482ef18e6d9e12ba4810ce7845f9f991cb95bc | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 126 | 182 | 6 | 12f3d0f60db462f2a9799b3a06005bc871670760 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 190 | 182 | 7 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 190 | 182 | 7 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 190 | 182 | 7 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.34e-05 | 190 | 182 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 190 | 182 | 7 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 182 | 7 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-05 | 192 | 182 | 7 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 192 | 182 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-05 | 193 | 182 | 7 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-05 | 193 | 182 | 7 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 195 | 182 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 197 | 182 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 197 | 182 | 7 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.70e-05 | 197 | 182 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-05 | 200 | 182 | 7 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-05 | 200 | 182 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.87e-05 | 200 | 182 | 7 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-05 | 134 | 182 | 6 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.52e-05 | 141 | 182 | 6 | 399380de5ea09e22fd128e3e55fffeffc4874c15 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.76e-05 | 158 | 182 | 6 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.06e-05 | 165 | 182 | 6 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.48e-05 | 167 | 182 | 6 | 3461d14e36f09ddc6ee5549ca4797e16d3f37fcc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 170 | 182 | 6 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 170 | 182 | 6 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 170 | 182 | 6 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 7.38e-05 | 171 | 182 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.87e-05 | 173 | 182 | 6 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.87e-05 | 173 | 182 | 6 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.87e-05 | 173 | 182 | 6 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-05 | 173 | 182 | 6 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.12e-05 | 174 | 182 | 6 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 176 | 182 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.93e-05 | 177 | 182 | 6 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.21e-05 | 178 | 182 | 6 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-05 | 179 | 182 | 6 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.49e-05 | 179 | 182 | 6 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.79e-05 | 180 | 182 | 6 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 182 | 182 | 6 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 183 | 182 | 6 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.07e-04 | 183 | 182 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 184 | 182 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 184 | 182 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 1.14e-04 | 185 | 182 | 6 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.14e-04 | 185 | 182 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 185 | 182 | 6 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 116 | 182 | 5 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.17e-04 | 186 | 182 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.17e-04 | 186 | 182 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| Drug | C1 11-32 | 3.85e-09 | 18 | 180 | 6 | CID000443077 | |
| Drug | C11131 | 3.85e-09 | 18 | 180 | 6 | CID000443076 | |
| Drug | T4-G | 5.59e-09 | 19 | 180 | 6 | CID000152424 | |
| Drug | estriol-16-glucuronide | 1.10e-08 | 21 | 180 | 6 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 2.03e-08 | 23 | 180 | 6 | CID000066651 | |
| Drug | harmol | 2.57e-08 | 40 | 180 | 7 | CID000068094 | |
| Drug | testosterone glucuronide | 3.08e-08 | 41 | 180 | 7 | CID000108192 | |
| Drug | L-idaro-1,4-lactone | 7.32e-08 | 28 | 180 | 6 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 9.17e-08 | 29 | 180 | 6 | CID000125641 | |
| Drug | AC1Q6OQG | 2.08e-07 | 33 | 180 | 6 | CID000009686 | |
| Drug | AC1NOWCJ | 3.01e-07 | 35 | 180 | 6 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 3.01e-07 | 35 | 180 | 6 | CID010436171 | |
| Drug | estrone-3-glucuronide | 3.01e-07 | 35 | 180 | 6 | CID000115255 | |
| Drug | UDP-alpha-d-xylopyranose | 4.66e-07 | 60 | 180 | 7 | CID000001165 | |
| Drug | 2-AF | 8.03e-07 | 41 | 180 | 6 | CID000005800 | |
| Drug | androsterone glucuronide | 1.07e-06 | 43 | 180 | 6 | CID000114833 | |
| Drug | Meldola | 1.11e-06 | 68 | 180 | 7 | CID000081507 | |
| Drug | Hymecromone | 1.37e-06 | 25 | 180 | 5 | ctd:D006923 | |
| Drug | scopoletin | 2.67e-06 | 50 | 180 | 6 | CID005280460 | |
| Drug | AC1NQGK1 | 3.38e-06 | 52 | 180 | 6 | CID005195977 | |
| Drug | oxazepam | 3.79e-06 | 53 | 180 | 6 | CID000004616 | |
| Drug | phenolphthalin | 4.80e-06 | 5 | 180 | 3 | CID000066494 | |
| Drug | Amobarbital | 4.80e-06 | 5 | 180 | 3 | ctd:D000654 | |
| Drug | BP-3,6-quinol | 5.79e-06 | 33 | 180 | 5 | CID000119292 | |
| Drug | 7-methoxycoumarin | 5.83e-06 | 57 | 180 | 6 | CID000010748 | |
| Drug | phenolphthalein | 6.46e-06 | 58 | 180 | 6 | CID000004764 | |
| Drug | urochloralic acid | 7.15e-06 | 59 | 180 | 6 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 7.15e-06 | 59 | 180 | 6 | CID000007103 | |
| Drug | SN-38G | 7.15e-06 | 59 | 180 | 6 | CID000443154 | |
| Drug | p-nitroanisole | 8.54e-06 | 92 | 180 | 7 | CID000007485 | |
| Drug | lorcaserin | 9.55e-06 | 6 | 180 | 3 | ctd:C506658 | |
| Drug | l-borneol | 1.04e-05 | 37 | 180 | 5 | CID000010049 | |
| Drug | 3-OHBaP | 1.05e-05 | 63 | 180 | 6 | CID000025890 | |
| Drug | 6-deoxyerythronolide B | 1.21e-05 | 97 | 180 | 7 | CID000121904 | |
| Drug | 1-naphthol | 1.30e-05 | 98 | 180 | 7 | CID000007005 | |
| Drug | AC1L1OBF | 1.66e-05 | 20 | 180 | 4 | CID000032736 | |
| Drug | ranirestat | 1.66e-05 | 7 | 180 | 3 | ctd:C115070 | |
| Drug | 3-hydroxyandrostan-17-one | 1.69e-05 | 102 | 180 | 7 | CID000000225 | |
| Drug | methoxyresorufin | 1.78e-05 | 69 | 180 | 6 | CID000119220 | |
| Drug | uridine 5'-diphosphoglucuronic acid | 2.04e-05 | 189 | 180 | 9 | CID000000390 | |
| Drug | chrysin | 2.17e-05 | 106 | 180 | 7 | CID005281607 | |
| Drug | 7,8-benzoquinoline | 2.20e-05 | 43 | 180 | 5 | CID000009191 | |
| Drug | 2,2,2-trichloroethanol | 2.46e-05 | 73 | 180 | 6 | CID000008259 | |
| Drug | MS-222 | 2.47e-05 | 44 | 180 | 5 | CID000011400 | |
| Drug | 7-hydroxycoumarin | 2.88e-05 | 75 | 180 | 6 | CID005281426 | |
| Drug | Epiandrosterone [481-29-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.19e-05 | 200 | 180 | 9 | 5687_DN | |
| Drug | 16-epiestriol | 3.34e-05 | 77 | 180 | 6 | CID000003269 | |
| Drug | UDP-N-acetylglucosamine | GNPTAB EXT1 PGM1 UGT2A3 UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 | 3.58e-05 | 203 | 180 | 9 | CID000001167 |
| Drug | sobetirome | 3.60e-05 | 78 | 180 | 6 | CID009862248 | |
| Drug | benzyloxyresorufin | 3.60e-05 | 78 | 180 | 6 | CID000114982 | |
| Drug | AC1N8H7N | 3.60e-05 | 78 | 180 | 6 | CID004318740 | |
| Drug | salicylamide | 3.80e-05 | 48 | 180 | 5 | CID000005147 | |
| Drug | alpha-naphthoflavone | 4.33e-05 | 118 | 180 | 7 | CID000011790 | |
| Drug | acridine | 4.46e-05 | 81 | 180 | 6 | CID000009215 | |
| Drug | licochalcone A | 5.75e-05 | 27 | 180 | 4 | ctd:C070840 | |
| Drug | acetaminophen | EXT1 CEP43 AVIL UGT2A3 UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 SEC13 | 6.07e-05 | 270 | 180 | 10 | CID000001983 |
| Drug | Menthol | 6.67e-05 | 28 | 180 | 4 | ctd:D008610 | |
| Drug | menthol | 6.67e-05 | 87 | 180 | 6 | CID000001254 | |
| Drug | pentoxyresorufin | 6.67e-05 | 87 | 180 | 6 | CID000107683 | |
| Drug | 1,4-benzodiazepine | 7.65e-05 | 11 | 180 | 3 | CID000148431 | |
| Drug | 3 alpha,6 alpha-dihydroxy-5 beta-cholanoic acid | 7.69e-05 | 29 | 180 | 4 | CID000006747 | |
| Drug | Anilino | 7.69e-05 | 29 | 180 | 4 | CID000137550 | |
| Drug | 2-naphthol | 9.69e-05 | 93 | 180 | 6 | CID000008663 | |
| Drug | 3-methylcholanthrene | 9.70e-05 | 231 | 180 | 9 | CID000001674 | |
| Drug | 9-methyluric acid | 1.01e-04 | 31 | 180 | 4 | CID000108714 | |
| Drug | 4-hydroxyestrone | 1.04e-04 | 59 | 180 | 5 | CID000018418 | |
| Drug | acetaminophen glucuronide | 1.04e-04 | 59 | 180 | 5 | CID000083944 | |
| Drug | dioxin | NRIP1 CEMIP2 CSK UGT2A3 UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 SCIN TNXB | 1.05e-04 | 347 | 180 | 11 | CID000015625 |
| Drug | ethoxyresorufin | 1.09e-04 | 95 | 180 | 6 | CID000003294 | |
| Drug | DCNB | 1.09e-04 | 95 | 180 | 6 | CID000007443 | |
| Drug | NNAL | 1.14e-04 | 32 | 180 | 4 | CID000104856 | |
| Drug | R(-)-Denopamine | 1.29e-04 | 33 | 180 | 4 | CID000003818 | |
| Drug | hydroxyphenylacetic acid | 1.29e-04 | 33 | 180 | 4 | CID000011970 | |
| Drug | Digoxigenin [1672-46-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.40e-04 | 190 | 180 | 8 | 4680_DN | |
| Drug | phenobarbital | LIPF GRIA2 GRIN2C PBRM1 UGT2A3 UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 KCNQ3 | 1.45e-04 | 360 | 180 | 11 | CID000004763 |
| Drug | AC1L45AJ | 1.46e-04 | 34 | 180 | 4 | CID000200882 | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.67e-04 | 195 | 180 | 8 | 2394_UP | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; PC3; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 5084_UP | |
| Drug | ST021200; Down 200; 10uM; PC3; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 7559_DN | |
| Drug | Fosfosal [6064-83-1]; Up 200; 18.4uM; PC3; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 4239_UP | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 5780_UP | |
| Drug | oxazepam glucuronide | 1.86e-04 | 3 | 180 | 2 | ctd:C026256 | |
| Drug | 1,8-dinitro-4,5-dihydroxyanthraquinone | 1.86e-04 | 3 | 180 | 2 | ctd:C538818 | |
| Drug | 5 alpha-dihydroaldosterone | 1.86e-04 | 3 | 180 | 2 | CID003036614 | |
| Drug | desmycosin | 1.86e-04 | 3 | 180 | 2 | CID006437804 | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; HL60; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 1863_UP | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.98e-04 | 200 | 180 | 8 | 3238_DN | |
| Drug | AC1L7AJI | PTPRD UGT2A3 UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 ADAM17 TOP2B | 2.10e-04 | 256 | 180 | 9 | CID000003750 |
| Drug | baciphelacin | 2.33e-04 | 70 | 180 | 5 | CID000171612 | |
| Drug | 2-naphthylamine | 2.44e-04 | 110 | 180 | 6 | CID000007057 | |
| Disease | X-19141 measurement | 8.58e-07 | 13 | 177 | 4 | EFO_0800799 | |
| Disease | X-24947 measurement | 8.41e-06 | 22 | 177 | 4 | EFO_0800910 | |
| Disease | deoxycholic acid glucuronide measurement | 1.16e-05 | 8 | 177 | 3 | EFO_0800575 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.74e-05 | 9 | 177 | 3 | EFO_0600040 | |
| Disease | Abnormality of the sense of smell, COVID-19 symptoms measurement, ageusia | 3.58e-05 | 2 | 177 | 2 | EFO_0600019, EFO_1001758, HP_0004408 | |
| Disease | cholic acid glucuronide measurement | 1.07e-04 | 3 | 177 | 2 | EFO_0800574 | |
| Disease | serine/threonine-protein kinase BRSK2 measurement | 1.07e-04 | 3 | 177 | 2 | EFO_0803063 | |
| Disease | Joubert syndrome 4 (is_implicated_in) | 1.07e-04 | 3 | 177 | 2 | DOID:0110999 (is_implicated_in) | |
| Disease | Gastric Adenocarcinoma | 1.54e-04 | 45 | 177 | 4 | C0278701 | |
| Disease | X-25937 measurement | 2.13e-04 | 4 | 177 | 2 | EFO_0800937 | |
| Disease | androsterone glucuronide measurement | 2.24e-04 | 20 | 177 | 3 | EFO_0800317 | |
| Disease | Joubert syndrome 1 | 2.61e-04 | 21 | 177 | 3 | C4551568 | |
| Disease | JOUBERT SYNDROME 17 | 3.54e-04 | 5 | 177 | 2 | C3553264 | |
| Disease | urate measurement, bone density | DHX33 GRIN2C CASZ1 TIAM2 TG FSIP2 PPARGC1A HEATR6 PTPRD MAPK8 TNXB MYO16 | 3.82e-04 | 619 | 177 | 12 | EFO_0003923, EFO_0004531 |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 6.26e-04 | 239 | 177 | 7 | EFO_0010934 | |
| Disease | vanillylmandelate (VMA) measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0800119 | |
| Disease | X-24574 measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0800897 | |
| Disease | X-24418 measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0800879 | |
| Disease | Familial aplasia of the vermis | 7.65e-04 | 30 | 177 | 3 | C0431399 | |
| Disease | nephrotic syndrome | 8.89e-04 | 71 | 177 | 4 | EFO_0004255 | |
| Disease | loneliness measurement | 9.29e-04 | 124 | 177 | 5 | EFO_0007865 | |
| Disease | Schizophrenia | NRIP1 AHI1 MYO5B GRIA2 IDE GRIN2C ZNF804A PPARGC1A PBRM1 ERVK-8 KCNQ3 MAPK8 TNXB MYO16 | 9.30e-04 | 883 | 177 | 14 | C0036341 |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 9.78e-04 | 8 | 177 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | NEPHRONOPHTHISIS 2 | 9.78e-04 | 8 | 177 | 2 | C1865872 | |
| Disease | cathepsin Z measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0008074 | |
| Disease | lysosomal Pro-X carboxypeptidase measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0801777 | |
| Disease | microcephaly (is_implicated_in) | 9.78e-04 | 8 | 177 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | intellectual disability (implicated_via_orthology) | 1.09e-03 | 75 | 177 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | malignant epithelial tumor of ovary | 1.21e-03 | 35 | 177 | 3 | MONDO_0018364 | |
| Disease | alkaline phosphatase measurement | RALGAPA1 MINK1 NWD2 SLC30A5 SLC4A1AP NFATC3 SLF2 RECQL4 UGT2B4 UGT2B7 UGT2B15 UGT2B17 RP1 RIC1 DCAF12 | 1.24e-03 | 1015 | 177 | 15 | EFO_0004533 |
| Disease | Nephronophthisis | 1.25e-03 | 9 | 177 | 2 | cv:C0687120 | |
| Disease | nephronophthisis (implicated_via_orthology) | 1.25e-03 | 9 | 177 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0800275 | |
| Disease | X-12844 measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0021339 | |
| Disease | serum gamma-glutamyl transferase measurement | BRIP1 TWNK SLC6A15 ZNF804A PGM1 EVA1C PBRM1 UGT2B4 UGT2B7 UGT2B15 RP1 DCAF4 FKBP5 DMTN | 1.29e-03 | 914 | 177 | 14 | EFO_0004532 |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0022090 | |
| Disease | thyroxine measurement | 1.59e-03 | 83 | 177 | 4 | EFO_0005130 | |
| Disease | Disorder of eye | 1.82e-03 | 212 | 177 | 6 | C0015397 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.90e-03 | 11 | 177 | 2 | EFO_0801531 | |
| Disease | atopic dermatitis (implicated_via_orthology) | 1.90e-03 | 11 | 177 | 2 | DOID:3310 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.91e-03 | 41 | 177 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.91e-03 | 41 | 177 | 3 | C0858252 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 2.27e-03 | 12 | 177 | 2 | C0403553 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0800291 | |
| Disease | coronary artery disease | ANKRD31 GLS2 PPP1R9A PPHLN1 ZNF831 MAPK8IP3 KIAA1217 PRIM2 UHRF1 KCNAB1 RP1 C5 TNXB UNC13A FKBP5 ANKS1A | 2.32e-03 | 1194 | 177 | 16 | EFO_0001645 |
| Disease | Neurodevelopmental Disorders | 2.41e-03 | 93 | 177 | 4 | C1535926 | |
| Disease | hypertension | 2.63e-03 | 307 | 177 | 7 | EFO_0000537 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 2.67e-03 | 13 | 177 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | Modic type vertebral endplate changes | 2.67e-03 | 13 | 177 | 2 | HP_0030775 | |
| Disease | skin and soft tissue Staphylococcus aureus infection | 2.67e-03 | 13 | 177 | 2 | EFO_1001489 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0800413 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0800293 | |
| Disease | Nephronophthisis | 2.67e-03 | 13 | 177 | 2 | C0687120 | |
| Disease | cortical thickness | TES GLS2 ZNF423 SLC6A15 EXT1 PGM1 MAPK8IP3 TG AGBL4 UBN1 CSK DOCK7 CDK5RAP2 MYO16 ANKS1A | 3.00e-03 | 1113 | 177 | 15 | EFO_0004840 |
| Disease | epilepsy (implicated_via_orthology) | 3.09e-03 | 163 | 177 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 3.11e-03 | 14 | 177 | 2 | EFO_0800283 | |
| Disease | obsolete_red blood cell distribution width | NRIP1 AHI1 BRIP1 ZNF280D RBL1 PBRM1 KIAA1217 TRIM56 UGT2A3 TMC8 UGT2B15 MAST1 RP1 PIBF1 DCAF4 MYO16 DCAF12 | 3.16e-03 | 1347 | 177 | 17 | EFO_0005192 |
| Disease | vitamin D measurement, COVID-19 | 3.19e-03 | 49 | 177 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | vital capacity | AHI1 SLC6A15 TRIP12 CASZ1 TIAM2 NCOR1 PTPRD UHRF1 PIBF1 METAP2 TNXB SF3B2 FKBP5 MYO16 SLC25A31 ANKS1A | 3.26e-03 | 1236 | 177 | 16 | EFO_0004312 |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 3.38e-03 | 50 | 177 | 3 | EFO_0010732 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.74e-03 | 105 | 177 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | mean arterial pressure, alcohol consumption measurement | 3.78e-03 | 52 | 177 | 3 | EFO_0006340, EFO_0007878 | |
| Disease | Huntington's disease (is_marker_for) | 3.99e-03 | 53 | 177 | 3 | DOID:12858 (is_marker_for) | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 4.21e-03 | 54 | 177 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | Metastatic melanoma | 4.21e-03 | 54 | 177 | 3 | C0278883 | |
| Disease | treatment-resistant hypertension | 4.27e-03 | 109 | 177 | 4 | EFO_1002006 | |
| Disease | Ciliopathies | 4.41e-03 | 110 | 177 | 4 | C4277690 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 4.59e-03 | 17 | 177 | 2 | cv:C0270914 | |
| Disease | endometrial carcinoma | 4.85e-03 | 113 | 177 | 4 | EFO_1001512 | |
| Disease | brain aneurysm | 4.85e-03 | 113 | 177 | 4 | EFO_0003870 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 4.90e-03 | 57 | 177 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 5.14e-03 | 18 | 177 | 2 | EFO_0800288 | |
| Disease | Drug habituation | 5.16e-03 | 115 | 177 | 4 | C0013170 | |
| Disease | Drug abuse | 5.16e-03 | 115 | 177 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 5.16e-03 | 115 | 177 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 5.16e-03 | 115 | 177 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 5.16e-03 | 115 | 177 | 4 | C0013222 | |
| Disease | Drug Dependence | 5.16e-03 | 115 | 177 | 4 | C1510472 | |
| Disease | Substance Dependence | 5.16e-03 | 115 | 177 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 5.16e-03 | 115 | 177 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.16e-03 | 115 | 177 | 4 | C0029231 | |
| Disease | neuroimaging measurement | BRSK2 EXT1 MSH5 PGM1 MAPK8IP3 TG JPH1 PPARGC1A NCOR1 CSK METAP2 MYO16 DMTN ANKS1A | 5.27e-03 | 1069 | 177 | 14 | EFO_0004346 |
| Disease | Substance abuse problem | 5.32e-03 | 116 | 177 | 4 | C0740858 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 5.65e-03 | 118 | 177 | 4 | EFO_0010119 | |
| Disease | etiocholanolone glucuronide measurement | 5.72e-03 | 19 | 177 | 2 | EFO_0800362 | |
| Disease | Intellectual Disability | 5.76e-03 | 447 | 177 | 8 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGLQAKDKTGSSDPY | 686 | Q9UPW8 | |
| KPGYITNSSRVVSNK | 126 | Q6N043 | |
| LTPNSKYVKLNVGGS | 36 | Q8WZ19 | |
| GSKYGIINLQSLKTP | 196 | Q8WV16 | |
| EGYKSAQKRAPQGEA | 2591 | A6H8Y1 | |
| NRLKVLYSQKATPGS | 146 | Q12834 | |
| GGKTPYANDKRLQQE | 596 | O75366 | |
| GNVKKLGDTYPSISN | 551 | Q9H4A4 | |
| SRRKNEKYLGFGTPS | 431 | O76031 | |
| GQYVKKDDSGRPVSS | 376 | Q8N157 | |
| TGENLRPQNGSTYKK | 321 | Q86V15 | |
| GNIYARDNRGKKPSD | 206 | Q8WXK3 | |
| PANYVQKREGVKAGT | 61 | P41240 | |
| ARSLPKVKALGYDGN | 756 | Q92625 | |
| GADVNYQSKEGKSPL | 296 | Q8NB46 | |
| QSLGYKDLGPNSSKT | 66 | P07384 | |
| KKQTGSGPLGNSYVE | 636 | Q9UER7 | |
| YNGKLTGPAAVELKR | 256 | Q96KQ4 | |
| SKYANQSAGKSGRRP | 1361 | Q9P241 | |
| NFGTGEQKRYNPSKT | 356 | Q9UHB7 | |
| IPSSQGYKKEGREQG | 496 | Q9UHB7 | |
| AYQDSPGEQKGIKTT | 1016 | Q96SN8 | |
| DGKNIGACSLYKTPT | 1606 | Q9ULI1 | |
| AYQDQKPGTSGLRKR | 11 | P36871 | |
| GLAEQYDVPKGSKNR | 426 | Q96L73 | |
| GQKLPKSRTAYSGGA | 221 | Q9Y388 | |
| SSPFKNGKYRTVGEQ | 1131 | Q4ADV7 | |
| INKLKTGGSRPGSYV | 386 | P52333 | |
| KGYRPVNSGNQAKDS | 406 | Q7Z3Y9 | |
| GANVNAKTKNGYTPL | 751 | Q01484 | |
| SNYDPKRGNRKTSSQ | 1611 | Q8N7Z5 | |
| RTKRKGEGYSNPNEG | 151 | Q13451 | |
| KIYGLTFGQKPNLRS | 181 | Q7Z5L7 | |
| QARSLGRPIKSSKQY | 36 | C9J6K1 | |
| SKGSLGEERNPTSKY | 316 | Q86U86 | |
| EPTQAAKLKGDYRTG | 5336 | Q9NU22 | |
| SAKNEKGYGPATQVR | 766 | Q9Y5Z7 | |
| KNTVSYSGKRKGPDS | 156 | Q9BYH8 | |
| DGKTYQVKPIRNLNG | 316 | P50579 | |
| KYKQLSPNGGQEDTR | 671 | Q9UPT6 | |
| REGPKLNSTAQKGYE | 636 | Q3T906 | |
| SPLSPQYSKSQKGDG | 1536 | Q9Y6X6 | |
| QYSKSQKGDGDRPAS | 1541 | Q9Y6X6 | |
| KYGNGVPESSRASLK | 306 | Q14722 | |
| RGSNTKGKLFTPLNV | 436 | O43525 | |
| SYNLKPGGDKISVTN | 596 | Q5U5R9 | |
| KEAGAVVPQSKYSGR | 521 | Q9HDC5 | |
| VGPYRLEKTLGKGQT | 16 | Q8IWQ3 | |
| ETKQAGKISNSPRYA | 2586 | Q5CZC0 | |
| GRNYSLGSPDLEKRK | 6576 | Q5CZC0 | |
| KGYGIATPKGSSLRN | 751 | P42262 | |
| VNRIPYGKKNSGNTG | 61 | P07098 | |
| YGKKNSGNTGQRPVV | 66 | P07098 | |
| TVLKRYQNLKPIGSG | 21 | P45983 | |
| GSKCQKYLPELLGNT | 151 | Q6AI08 | |
| GIIPSSPKNAGYKNS | 351 | P48552 | |
| SKPGGYRLFTQKLQE | 426 | P32456 | |
| GGKVAAYIPQLAKSN | 176 | Q9UI32 | |
| FVGKEPSGLRYNKLS | 241 | Q9UI32 | |
| LPQTRGDGKKIVSYQ | 201 | Q9Y2C4 | |
| TGPGKRYLQVSKNRF | 596 | Q96RR1 | |
| SLRLNSGNAFGKKYP | 351 | Q8IWF2 | |
| YLAFPTSKSSGQKGR | 581 | Q9NY59 | |
| QPTLGKKSDISRNAY | 241 | Q8TAM6 | |
| SSNGKAAYTGPKERV | 471 | P63135 | |
| SSNGKAAYTGPKERV | 471 | Q9BXR3 | |
| PKLKRNSNAYGIGAL | 41 | Q86XD5 | |
| SPITIQRSGKKYGFT | 966 | Q9Y2H9 | |
| GEGKGVNKRITYTNP | 1341 | O75161 | |
| NSLGQYFTGKIPKAT | 1006 | Q9BX63 | |
| GNNSTKKGPEQSELY | 341 | Q9UBK2 | |
| QKLQSYKISPGGISQ | 396 | P49643 | |
| SSNGKVAYTGPKERV | 471 | Q9QC07 | |
| YKPGRGTGVNSNSEK | 1181 | Q8NFC6 | |
| IGSSSILGSPENKKY | 876 | O60494 | |
| TQGAKRIGSPEYIKS | 231 | O43854 | |
| YGINFDPSGSKVLRK | 286 | P58658 | |
| QASSKQISPEARYKG | 51 | Q9H0C2 | |
| YKLPKRQNKESGETG | 46 | Q8WZ79 | |
| KQISGQYSGSPQLLK | 21 | Q96N67 | |
| SPRQKRDANSSIYKG | 81 | Q16394 | |
| TYGLRKEPRKQAGSL | 266 | O95684 | |
| YTKGQRLPKTVKNGT | 261 | A1L3X0 | |
| YGSKPRLAGENLKLT | 381 | Q5T6F0 | |
| TDSEYVKLAKQGGRP | 66 | Q8NEG2 | |
| RTKLNYNPPKDDGST | 56 | Q9H2C0 | |
| DSAVYGVQRGAKKPL | 606 | P01031 | |
| SKGYNQRPEGSKEES | 86 | Q7Z4B0 | |
| NGGSPITAFKVEYKR | 746 | Q4KMG0 | |
| LRGPASNYPNSKGDK | 476 | Q5VU57 | |
| KITASARGYNPVTKN | 841 | O75976 | |
| QGAPKGYRKVIISTN | 341 | Q9H6R0 | |
| KYVGTGGIDQKPRTL | 846 | Q9UHN6 | |
| VGPYRLEKTLGKGQT | 31 | Q8TDC3 | |
| SKFGTGNKYTLETRP | 216 | P14735 | |
| ITGRGTPSNRKKLEY | 6111 | Q8NDH2 | |
| KELQGPGYTSNSSLK | 846 | Q5M9N0 | |
| ERKNLIYSLPTSGGK | 351 | Q8TDG4 | |
| ENSGRLYLNPGKKRG | 111 | O95377 | |
| SEGPGTKYLKSNSRS | 426 | O76039 | |
| GNTGSGKTTQLPKYL | 76 | Q8IX18 | |
| IYKQRESVGGSPQTK | 146 | Q08495 | |
| PVPGYNNDTGKISSK | 201 | Q9BZW2 | |
| KDVTSGNAKIYQLPG | 221 | Q9NV23 | |
| GEAYQRKKAAATGLP | 156 | Q8N1S5 | |
| KSVRPGASYKRQNEG | 171 | Q8NEY8 | |
| YGSVQKSFADRGLPK | 236 | Q68BL7 | |
| KGTSKGRTGLIPSNY | 51 | Q92882 | |
| KPEKSYSFVLTNRGN | 1076 | P23468 | |
| PRNKVTQAKLTGGLY | 831 | Q9Y283 | |
| ISQRVYPKGNAKSES | 246 | P56715 | |
| DYQSRGLVKAPGKSS | 936 | Q8N4C8 | |
| TGPNSSGKSIYLKQV | 591 | O43196 | |
| PSGQKPNYIKRFASG | 171 | P55735 | |
| GKRYKNSLETVGTPD | 46 | O43581 | |
| GKNIYRKQSGSPTLD | 691 | Q9H2J7 | |
| PVAGSEGAQYRKKQL | 136 | Q9UGI8 | |
| GPYLLSKKGALQSRA | 516 | Q494U1 | |
| GDYNPGRKTSKTTSK | 1556 | Q02880 | |
| ARAYGGSATIVNKPK | 236 | Q9ULS5 | |
| SQRSPGLIYRNAKKS | 1496 | Q6T4R5 | |
| KNGSGLTPRSALLYK | 991 | P28749 | |
| SGKDGIKQYANTSVP | 1171 | Q8NE09 | |
| NSLGGKKDYQTSPLL | 591 | Q9Y6U3 | |
| GSKGRSEKIRTYNFP | 316 | Q9UGC7 | |
| SVPDYGQRLKANLKG | 101 | O94761 | |
| LGRYQTPDKKGQTQI | 271 | Q7Z6M4 | |
| KYGLPGLAQLKSRES | 66 | Q14249 | |
| NSRKSKSPIPGQGYL | 2331 | O75376 | |
| NKGSKISGLQYSIPD | 1281 | Q5T5P2 | |
| APTRGYEKDVGNKTT | 326 | Q96JF0 | |
| LDSPQKSNIKYGGSR | 66 | Q8IX21 | |
| LAEKRYQSPKNRLGG | 1151 | Q9P2P6 | |
| YPGDSRVQKKLGPTS | 3876 | Q9P2P6 | |
| NPGVRYKSKPLDNAS | 191 | O00186 | |
| SKGQGVNNVPKRYSL | 11 | Q68D10 | |
| AGANEGTPNKEKYRR | 911 | Q13972 | |
| KAEPYETSQGKGTPR | 66 | Q86UE8 | |
| SPVGKKNIYLNSGLT | 371 | P78536 | |
| SFSYKSLRKGGPSQR | 61 | P29973 | |
| SSNGKAAYTGPKERV | 471 | P63136 | |
| RKAQPQDSRGGSKKY | 876 | Q13435 | |
| GKYSLNSGAVKNPKT | 201 | P13682 | |
| SETPYLLKETNKGNG | 286 | Q9ULJ3 | |
| VPGKGSRKTYGSINL | 211 | Q9NUR3 | |
| KTLLGQGYQAPLSAK | 231 | Q8IU68 | |
| GGLQKNKSTGLTTPY | 1856 | Q6GYQ0 | |
| EGRQDSKSTSPGKYP | 1536 | Q8IVF5 | |
| PTSQQKGSRGKSYGR | 161 | B3KS81 | |
| SKRLSYQGQSRDKLP | 556 | Q9BW04 | |
| GNKPDTLGLNTRLYK | 341 | P06133 | |
| TLFGIANKKRYGPLT | 1226 | P22105 | |
| ANKKRYGPLTADGTT | 1231 | P22105 | |
| SSNGKAAYTGPKERV | 471 | P10266 | |
| GYGANVPTTAKRRLK | 561 | Q8WXW3 | |
| SSNGKAAYTGPKERV | 471 | P63133 | |
| TSIDDGLGSQYPLKK | 371 | Q12968 | |
| SSNGKAAYTGPKERV | 471 | Q9UQG0 | |
| YSAKGPTTKSDGNRE | 96 | Q9BZD6 | |
| AGVSQSPRYKVTKRG | 21 | A0A1B0GX31 | |
| AGVSQSPRYKVTKRG | 21 | A0A0K0K1E9 | |
| KGEVPNGYNVSRLNK | 76 | A0A0K0K1D8 | |
| KSVKYGGSRQQLPDN | 306 | Q8N9V2 | |
| KTSGPYKDVPTDQRG | 206 | P10073 | |
| KPLQKGQTAYQRKGS | 336 | Q9UBW7 | |
| PLSKSYSSGNRKGFL | 46 | O43615 | |
| VRNVKGGKNSKYAPA | 536 | Q96T88 | |
| GGSPRKKVALTENYE | 1941 | Q9UPU5 | |
| LGQSSQEKKPESSGY | 746 | Q9NPG3 | |
| PKAGISRSSSQGKAY | 6 | P17026 | |
| SKRGQKGTLIGYSPE | 366 | Q8TAD4 | |
| RYKGKKPSTLGANTR | 336 | Q6UWM9 | |
| AASSPNGQGLQKLYK | 1051 | Q2M1K9 | |
| DGKKPNTLGSNTRLY | 341 | P54855 | |
| KTKNLGEPEDYGRTS | 346 | Q5QJ38 | |
| TLGSPGKVRNAGKYL | 131 | Q5JPB2 | |
| GNKPDTLGLNTRLYK | 341 | P16662 | |
| KSSVTKGGPQIAYER | 531 | Q9H0M0 | |
| TLSNPKGSQEGTKYI | 1656 | Q14669 | |
| QDSPAVYLKKGQGST | 1671 | P01266 | |
| RYKGKKPATLGNNTQ | 336 | P0DTE4 | |
| ISYETNVLGFKGPRK | 306 | O75386 | |
| SRGSKKNYQSQADIP | 366 | Q14966 | |
| AGVSQSPRYKVAKRG | 21 | A0A1B0GX51 | |
| TPLQKGQTAYQRKGL | 316 | Q14202 | |
| DGKKPNTLGSNTRLY | 341 | O75795 | |
| NRSVKADSTKYNGPP | 881 | Q9BVV6 | |
| YKGKKPATLGNNTQL | 346 | P0DTE5 | |
| AGVSQSPRYKVAKRG | 21 | A0A1B0GX95 | |
| LKRFSLNGDYKGTVP | 531 | Q9BRZ2 | |
| RGPLSKNGNKTLDYA | 26 | Q7Z570 | |
| SIQGLSGVKPTGYRK | 1626 | Q9ULV0 | |
| AIKSYQGKSLGTRPP | 111 | Q9UM54 | |
| AGPSASKNEYEKSRG | 731 | Q9BWU0 | |
| VRPTFSKYLALNGKG | 456 | Q9UBF9 | |
| GKDASKRGRQTPVLY | 206 | P25189 | |
| NNRYSPKKEKAGGSE | 156 | Q9ULJ8 | |
| SYNQNLTRGKKSGGP | 581 | Q14957 |